文献速递角膜与眼表疾病

未治疗圆锥角膜进展预测因素:Save Sight圆锥角膜登记研究

Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study.
PubMed 文献 · Br J Ophthalmol · 2021-03-30

本研究基于澳大利亚、新西兰、西班牙和意大利34个中心的2283例患者共3994只未治疗眼,按视力、最大角膜曲率和最薄角膜厚度分为进展组与稳定组。3年内视力、Max-K和TCT进展比例分别为3.2%、6.6%和3.1%(1年数据)。基线Max-K更陡和年龄更轻是与两个临床参数恶化相关的最有用基线预测因素。

要点

  • 基线Max-K每陡1D,视力恶化风险增加7%,TCT变薄风险增加3%。
  • 年龄每年轻1岁,Max-K变陡风险增加4%,TCT变薄风险增加2%。
  • 基线Max-K更陡和年龄更轻与两个临床参数进展相关,最具临床实用性。

核心结论

  • 基线Max-K更陡和年龄更轻是与视力恶化及TCT变薄两个参数进展相关的最有用基线预测因素。

研究设计与样本

  • 基于Save Sight圆锥角膜登记研究,纳入澳大利亚、新西兰、西班牙和意大利34个中心的2283例患者共3994只未治疗眼,按VA、Max-K和TCT分别分为进展组与稳定组。

主要发现

  • 1年时视力、Max-K和TCT进展的眼比例分别为3.2%、6.6%和3.1%。
  • 视力下降与基线视力较高(HR 1.15每logMAR行增加;p<0.001)和基线Max-K较陡(HR 1.07每1D增加;p<0.001)相关。
  • Max-K变陡与基线年龄较轻相关(HR 0.96每岁增加;p=0.001)。
  • TCT变薄与基线TCT较厚(HR 1.08每10 µm增加;p<0.001)、基线Max-K较陡(HR 1.03每1D增加;p=0.02)和基线年龄较轻(HR 0.98每岁年轻;p=0.01)相关。

关键数值与推荐

  • 基线Max-K每陡1D,视力恶化风险增加7%,TCT变薄风险增加3%。
  • 年龄每年轻1岁,Max-K变陡风险增加4%,TCT变薄风险增加2%。

临床怎么用

  • 对未治疗圆锥角膜患者,基线Max-K较陡和年龄较轻提示进展风险较高,可考虑更密切随访。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We set out to identify risk factors for progression in untreated keratoconus patients from 34 centres across Australia, New Zealand, Spain and Italy. METHODS: Patients were divided into 'progressors' and 'stable' patients for each clinical parameter: visual acuity (VA), steepest keratometry (maximum keratometry (Max-K)) and thinnest corneal thickness (TCT). Primary outcomes were the proportion of eyes with sustained progression in VA, Max-K or TCT within 3 years. Secondary outcomes included predictors of progression. RESULTS: There were 3994 untreated eyes from 2283 patients. The proportion of eyes with VA, Max-K and TCT progression at 1 year were 3.2%, 6.6% and 3.1% respectively. Factors associated with VA loss were higher baseline VA (HR 1.15 per logMAR line increase in VA; p<0.001) and steeper baseline Max-K (HR 1.07 per 1D increase; p<0.001). Younger baseline age was associated with Max-K steepening (HR 0.96 per year older; p=0.001). Thicker baseline TCT, steeper baseline Max-K and younger baseline age were associated with TCT thinning: (HR 1.08 per 10 µm increase in TCT; p<0.001), (HR 1.03 per 1D increase; p=0.02) and (HR 0.98 per year younger; p=0.01), respectively. CONCLUSIONS: Steeper Max-K and younger age were the most clinically useful baseline predictors of progression as they were associated with worsening of two clinical parameters. Every 1D steeper Max-K was associated with a 7% and 3% greater risk of worsening VA and thinning TCT, respectively. Each 1 year younger was associated with a 4% and 2% greater risk of steepening Max-K and thinning TCT, respectively.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ferdi A, Nguyen V, Kandel H, et al. Predictors of progression in untreated keratoconus: a Save Sight Keratoconus Registry study. Br J Ophthalmol. 2021. PMID: 33785509. doi:10.1136/bjophthalmol-2020-317547

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。